Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K974494
    Manufacturer
    Date Cleared
    1998-02-10

    (74 days)

    Product Code
    Regulation Number
    872.3310
    Panel
    Dental
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Renamel Flowable Composite is used for Class V restorations, small occlusal restorations, to seal margins, to repair pitted areas in restorations, as a pit and fissure sealant, to repair marginal defects, for bonding of fibrous splints and for direct resin veneers.

    Device Description

    Renamel Flowable Composite is a system consisting of light-cured flowable composite restorative dental materials.

    AI/ML Overview

    I am sorry, but the provided text does not contain the detailed information necessary to answer your request about acceptance criteria and a study proving device performance for the "Renamel Flowable Composite" device.

    The document is a 510(k) clearance letter from the FDA, which confirms that the device is substantially equivalent to legally marketed predicate devices. It covers:

    • Device Name: Renamel Flowable Composite
    • Manufacturer: Cosmedent, Incorporated
    • Regulatory Class: II
    • Product Code: EBD
    • Date of Clearance: February 10, 1998
    • Indications for Use: Class V restorations, small occlusal restorations, to seal margins, to repair pitted areas in restorations, as a pit and fissure sealant, to repair marginal defects, for bonding of fibrous splints and for direct resin veneers.
    • Device Description: A system consisting of light-cured flowable composite restorative dental materials. It also mentions a "confidential chemical analysis... in Appendix C," which is not provided.

    However, the letter does not include:

    • Specific acceptance criteria for performance.
    • Details of any study (like sample sizes, data provenance, expert qualifications, ground truth establishment, MRMC studies, or standalone performance).
    • Any performance metrics or results.

    For a 510(k) submission, the primary aim is to demonstrate substantial equivalence to a predicate device, not necessarily to conduct de novo clinical trials with strict performance criteria and detailed study designs as might be found in a PMA (Premarket Approval) application or a more recent clinical study report. The FDA concluded that the device is substantially equivalent, implying that its performance characteristics are comparable to existing, legally marketed devices.

    Therefore, I cannot populate the table or answer the specific questions about study design, sample sizes, expert involvement, or reported performance.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1